ArticleTranslational oncology2019

Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) Is Not Attributed to MSH3 Loss in Stage I-III Colon cancer: An Automated, Digitalized Assessment by Immunohistochemistry of Whole Slides and Hot Spots.

Martin M Watson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.